Találati lista | Tudóstér

001-es BibID:	BIBFORM027720
Első szerző:	Kárpáti István (belgyógyász, nephrológus)
Cím:	Disturbed LDL and scavenger receptor functions in monocytes from chronic haemodialysed patients / István Kárpáti, György Paragh, Éva Kovács, Zoltán Balogh, Márton Szabolcs, Jenő Szabó, György Kakuk, Gabriella Fóris
Dátum:	1999
Megjegyzések:	BACKGROUND: The most frequent complication in patients with end-stage renal failure on chronic haemodialysis (HD) treatment is atherosclerosis, i.e. the different forms of heart and vascular diseases. The complete disorder of serum lipid and lipoprotein patterns is well demonstrated, whereas our knowledge about the low-density lipoprotein (LDL) and scavenger receptor expression and function are poorly understood. METHODS: In our current work, LDL and scavenger receptor expression and functions were simultaneously studied in monocytes obtained from 15 healthy male control subjects and from 11 chronic HD male patients applied with (125)I-labelled LDL, isolated from healthy volunteers. To study the scavenger LDL receptors, labelled acetylated LDL (acLDL) was used. RESULTS: LDL binding to the monocytes of the HD-group was found to be decreased in comparison to that of the controls. As a result, the 50 microg LDL protein-induced inhibition of endogenous cholesterol synthesis was also diminished. In contrast, acLDL binding was greatly increased, though it could trigger only a low apoE synthesis. Consequently the number of cholesterol inclusions in monocytes was increased. CONCLUSIONS: The disturbed expression and function of LDL and scavenger receptors both may play significant roles in pathogenesis of cardiovascular complications in chronic HD patients. Based on our present results, it can be assumed that dysfunction of scavenger receptors is at the centre of cardiovascular complications of HD patients with renal failure.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:	Nephrology, Dialysis, Transplantation. - 14 : 11 (1999), p. 2664-2668. -
További szerzők:	Paragh György (1953-) (belgyógyász) Kovács Éva Balogh Zoltán (1965-) (belgyógyász, gasztroenterológus, diabetológus) Szabolcs Márton Szabó Jenő (belgyógyász, endocrinologus) Kakuk György (1938-2018) (belgyógyász) Fóris Gabriella (1937-) (belgyógyász)
Internet cím:	Intézményi repozitóriumban (DEA) tárolt változat DOI
Borító:
Saját polcon:

001-es BibID:	BIBFORM017499
Első szerző:	Paragh György (belgyógyász)
Cím:	Altered signal pathway in angiotensin II-stimulated neutrophils of patients with hypercholesterolemia / György Paragh, Jenő Szabó, Éva Kovács, Tamás Keresztes, István Kárpáti, Zoltán Balogh, Dénes Páll, Gabriella Fóris
Dátum:	2002
ISSN:	0898-6568
Megjegyzések:	Angiotensin II (AII) in 1-10 nM concentrations has an in vivo immunostimulating effect on human neutrophils. The release of superoxide anions and leukotrienes (LTs) is significantly increased by 10 nM AII-stimulated neutrophils of patients with hypercholesterolaemia (HCH). These oxidizing agents may be involved in the damage of vessel walls, i.e., in atherosclerotic plaque formation. To clarify the receptor types and signal pathways in neutrophils of healthy controls and patients, inositol trisphosphate (IP(3)) production and Ca(2+) signalling were studied. Neutrophils were pretreated before AII stimulation with different inhibitory drugs. In control cells, the stimulation occurred predominantly through pertussis toxin-sensitive, type angiotensin 1 receptors. This induced IP(3) production and Ca(2+) signalling from intracellular pools. In neutrophils of hypercholesterolaemic patients, the enhanced release of oxidizing agents was dependent more on type angiotensin 2 than type angiotensin 1 receptors. After stimulation, there was no IP(3) production detected. The Ca(2+) signalling was lower than in control cells and was dependent on extracellular Ca(2+).
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
Megjelenés:	Cellular Signalling. - 14 : 9 (2002), p. 787-792. -
További szerzők:	Szabó Jenő (belgyógyász, endocrinologus) Kovács Éva Keresztes Tamás Kárpáti István (1955-) (belgyógyász, nephrológus) Balogh Zoltán (1965-) (belgyógyász, gasztroenterológus, diabetológus) Páll Dénes (1967-) (belgyógyász, kardiológus) Fóris Gabriella (1937-) (belgyógyász)
Internet cím:	Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon:

001-es BibID:	BIBFORM017419
Első szerző:	Paragh György (belgyógyász)
Cím:	Treatment possibility of hypercholesterolaemia associated with hypertriglyceridaemia / Paragh Gy., Balogh Z., Boda J., Kovács P., Kárpáti I., Szabó J., Leövey A.
Dátum:	1997
Megjegyzések:	Thirty patients were investigated with hyperlipoproteinaemia, 15 patients with non-insulin dependent diabetes mellitus (NIDDM) and 15 with primary hyperlipoproteinaemia. The patients took 250 mg acipimox (5-metyl-pyrazine-carboxylic acid 4-oxide) 3 times per day for 2 months. Serum examinations were performed before and after 1 and 2 months of acipimox administration. After treatment the cholesterol and triglyceride levels decreased in both groups. Patients with NIDDM had 11% increase of high density lipoprotein-cholesterol (HDL-C) level at the end of the first, and 18% increase at the end of the second month, while patients with primary hyperlipoproteinaemia did not change significantly. The low density lipoprotein (LDL) level did not change significantly in either groups of patients. The apolipoprotein A 1 (apo A 1) levels increased significantly during the second month of acipimox administration. Uric acid levels decreased in both groups, but significant change could be detected mainly in the NIDDM group. Serum glucose level did not change in the non-diabetic patients, while it decreased significantly in the NIDDM group.
Tárgyszavak:	Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény hazai lapban
Megjelenés:	Acta Biologica Hungarica. - 48 : 3 (1997), p. 359-367. -
További szerzők:	Balogh Zoltán (1965-) (belgyógyász, gasztroenterológus, diabetológus) Boda Judit (belgyógyász, endokrinológus) Kovács Péter (1947-) (belgyógyász, kardiológus, klinikai farmakológus) Kárpáti István (1955-) (belgyógyász, nephrológus) Szabó Jenő (belgyógyász, endocrinologus) Leövey András (1926-) (belgyógyász)
Internet cím:	Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Saját polcon: